Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


The Global Aneurysm Clips Market is Predict to reach $102.9 Million by 2028, at a CAGR of 7.5%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Aneurysm Clips Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Aneurysm Clips Market size is expected to reach $102.9 Million by 2028, rising at a market growth of 7.5% CAGR during the forecast period.

The Polymer segment is showcasing a CAGR of 7.8% during (2022 - 2028). Till now, the aneurysm clips have been created of metal, which makes the follow-up tests with MRI (magnetic resonance imaging) difficult because of the distorted optical images. A clip made up from polymer will eliminate this issue. A few polymeric materials cause substantially lesser artifacts in MRI images. These polymeric materials can make aftercare easier and more cost-effective.

The Hospitals segment acquired maximum revenue share in the Global Aneurysm Clips Market by End-use in 2021 thereby, achieving a market value of $66 Million by 2028. This is credited to the increasing number of surgical processes, like neurosurgery and abdominal laparoscopy, and the rising occurrence of trauma. Therefore, the increase in surgical procedures performed in hospitals using clipping equipment had a positive impact on the segment's growth.

The Cerebral Aneurysm segment has shown the growth rate of 8.4% during (2022 - 2028). Cerebral artery stenosis occurs when an artery becomes blocked due to disease or plaque inside the skull. Factors like arteriovenous malformations, genetic conditions, smoking, and untreated high blood pressure cause aneurysms in the brain. The microsurgical clipping method is utilized in treating cerebral artery stenosis. Owing to this, the market growth is predicted to accelerate in this segment.

The North America market dominated the Global Aneurysm Clips Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $40 billion by 2028. The Europe market is exhibiting a CAGR of 7.1% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 8.1% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/aneurysm-clips-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Abbott Laboratories, Stryker Corporation, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), KLS Martin Group, Adeor Medical AG, and Evonos GmbH & Co.KG.

Global Aneurysm Clips Market Segmentation

By Material

  • Titanium Aneurysm Clips
  • Polymer
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Indication

  • Stroke
  • Cerebral Artery Stenosis
  • Cerebral Aneurysm
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Medtronic PLC
  • Abbott Laboratories
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • Boston Scientific Corporation
  • B. Braun Melsungen AG (Aesculap, Inc.)
  • Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
  • KLS Martin Group
  • Adeor Medical AG
  • Evonos GmbH & Co.KG

Related Reports:



SUBSCRIPTION MODEL